Qiang Liu - Guangdong Prov Key Lab Malignant Tumor Epigenet &, Sun Yat Sen Univ

基本信息

浏览量：226

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 115 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Analysis of Regulatory Patterns of NLRP3 Corpuscles and Related Genes and the Role of Macrophage Polarization in Atherosclerosis Based on Online Database

Wen Shen,Tao Wu,Qiang Liu,Ben Ke

MOLECULAR GENETICS AND GENOMICS（2025）

引用0浏览0WOS引用

Dynamic Ctdna Tracking Stratifies Relapse Risk for Triple Negative Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

Shunying Li, Yudong Li, Wei,Chang Gong, Ting Wang, Guangxin Li,Feng Yao,Jiang-Hua Ou,Yan Xu,Wei Wu, Liang Jin,Nanyan Rao,Yan Nie,Fengyan Yu,Weijuan Jia,Xing-Rui Li,Jun Zhang,Hua-Wei Yang,Yaping Yang, Mengzi Wu, Qin Li, Fang Li, Yuhua Gong,Xin Yi,Qiang Liu

Nature communicationsno. 1 (2025): 2786-2786

引用0浏览0WOSNATURE引用

Sequential Neoadjuvant Chemotherapy Using Pegylated Liposomal Doxorubicin and Cyclophosphamide Followed by Taxanes with Complete Trastuzumab and Pertuzumab Treatment for HER2-positive Breast Cancer: A Phase II Single-Arm Study

Yaping Yang,Liang Jin,Yudong Li,Nanyan Rao,Chang Gong,Shunrong Li,Jiannan Wu,Jinghua Zhao,Linxiaoxiao Ding, Fengxia Gan,Jun Zhang, Ruifa Feng,Zhenzhen Liu,Qiang Liu

CHINESE JOURNAL OF CANCER RESEARCHno. 1 (2024)

引用1浏览0WOS引用

Abstract PO1-28-04: PILHLE-001: neoadjuvant pyrotinib combined with chemotherapy in HR-positive, HER2-low (IHC 2+/FISH-negative) early breast cancer

Chang Gong,Yuan Xia,Yingying Zhu,Yaping Yang,Wenqian Yang,Louis W.C. Chow,Li Ling,Yunjie Zeng,Jiajie Zhong,Ziliang Cheng,Jun Shen,Qun Lin,Yinduo Zeng,Qiang Liu,Erwei Song

Cancer Researchno. 9_Supplement (2024): PO1-28

引用0浏览0引用

Toripalimab Plus Nab-Paclitaxel in Metastatic or Recurrent Triple-Negative Breast Cancer: a Randomized Phase 3 Trial

Nature Medicineno. 1 (2024): 249-256

引用20浏览0WOSNATURE引用

Tissue-informed personalized MRD detection assay may outperform tumor-informed fixed panel strategy in Triple Negative Breast Cancer (TNBC)

Shunying Li, Wei Gao, Ning Fu,Wuqiang Cao,Xiaoling Zeng, Xinhua Du,Qiang Liu

CANCER RESEARCHno. 9 (2024): PO5-16

引用0浏览0引用

The Anti-Pd-l1/ctla-4 Bispecific Antibody KN046 in Combination with Nab-Paclitaxel in First-Line Treatment of Metastatic Triple-Negative Breast Cancer: a Multicenter Phase II Trial

Qiao Li,Jiaxuan Liu,Qingyuan Zhang,Quchang Ouyang,Yang Zhang,Qiang Liu,Tao Sun,Feng Ye,Baochun Zhang,Summer Xia,Bangyong Zhang,Binghe Xu

NATURE COMMUNICATIONSno. 1 (2024)

引用10浏览0WOSNATURE引用

Can Patients with Biopsy-Diagnosed DCIS Safely Spare Sentinel Lymph Node Biopsy (SLNB)

Xinyu Li,Yudong Li,Qiang Liu

Journal of Clinical Oncology（2024）

引用0浏览0引用

Patient‐reported Outcome and Survival in Premenopausal Hormone Receptor‐positive Breast Cancer Patients at Moderate to High Risk: Comparing Toremifene with Aromatase Inhibitor in a Real‐world Study

Yaping Yang, Fengxia Gan, Ting Luo,Qun Lin,Wenqian Yang, Lili Chen, Wei Zhang,Qiang Liu,Chang Gong

MedCommno. 10 (2024)

引用0浏览0WOS引用

Deep Learning Combining Mammography and Ultrasound Images to Predict the Malignancy of BI-RADS US 4A Lesions in Women with Dense Breasts: a Diagnostic Study

Yaping Yang,Ying Zhong,Junwei Li, Jiahao Feng,Chang Gong,Yunfang Yu,Yue Hu,Ran Gu,Hongli Wang,Fengtao Liu,Jingsi Mei,Xiaofang Jiang,Jin Wang,Qinyue Yao, Wei Wu,Qiang Liu,Herui Yao

International Journal of Surgery (2024)

引用1浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn